Spirodiketopiperazine-based CCR5 antagonist: Discovery of an antiretroviral drug candidate
Following the discovery that hydroxylated derivative 3 (Fig. 1) was one of the oxidative metabolites of the original lead 1, it was found that hydroxylated compound 4 possesses higher in vitro anti-HIV potency than the corresponding non-hydroxylated compo
NOVEL CRYSTALS OF TRIAZASPIRO 5.5 UNDECANE DERIVATIVE
The present invention relates to a new crystal of triazaspiro[5.5]undecane derivatives. The crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydr
-
Page/Page column 16
(2008/06/13)
More Articles about upstream products of 674782-28-6